2126 fundamentals
An in-depth look to JW (CAYMAN) THERAPEUTICS CO. LTD operating, investing, and financing activities
2126 free cash flow for H2 24 is -166.03 M HKD. For 2024, 2126 free cash flow was -378.25 M HKD and operating cash flow was -372.53 M HKD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM